Merck & Co Inc [NYSE: MRK] traded at a low on Friday, posting a -0.13 loss after which it closed the day’ session at $81.71.
The results of the trading session contributed to over 12856583 shares changing hands. Over the past one week, the price volatility of Merck & Co Inc stands at 1.75% while the volatility over the past one month is 1.22%.
The market cap for MRK stock reached $205.18 billion, with 2.52 billion shares outstanding and 2.51 billion shares in the current float. Compared to the average trading volume of 16.15M shares, MRK reached a trading volume of 12856583 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Merck & Co Inc [MRK]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MRK shares is $102.10 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MRK stock is a recommendation set at 1.88. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Merck & Co Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 14, 2025. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Neutral. The new note on the price target was released on April 22, 2025, representing the official price target for Merck & Co Inc stock. Previously, the target price had yet another drop from $128 to $105, while Deutsche Bank kept a Hold rating on MRK stock. On February 10, 2025, analysts decreased their price target for MRK shares from 121 to 100.
The Average True Range (ATR) for Merck & Co Inc is set at 1.95, with the Price to Sales ratio for MRK stock in the period of the last 12 months amounting to 3.22. The Price to Book ratio for the last quarter was 4.25, with the Price to Cash per share for the same quarter was set at 3.72. Price to Free Cash Flow for MRK in the course of the last twelve months was 12.04 with Quick ratio for the last quarter at 1.16.
How has MRK stock performed recently?
Merck & Co Inc [MRK] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.47. With this latest performance, MRK shares gained by 11.22% in over the last four-week period, additionally sinking by -19.10% over the last 6 months – not to mention a drop of -38.02% in the past year of trading.
#####
Merck & Co Inc [MRK]: Deeper insight into the fundamentals
Merck & Co Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.16 and a Current Ratio set at 1.41.
Earnings analysis for Merck & Co Inc [MRK]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MRK. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Merck & Co Inc go to 11.66%.
Insider trade positions for Merck & Co Inc [MRK]
The top three institutional holders of MRK stocks are: VANGUARD GROUP INC with ownership of 244.68 million shares, which is approximately 9.6558%. BLACKROCK INC., holding 207.3 million shares of the stock with an approximate value of $$25.66 billion in MRK stocks shares; and BLACKROCK INC., currently with $$14.63 billion in MRK stock with ownership which is approximately 4.6365%.
